Erschienen in:
09.10.2020
Mouse models of growth hormone deficiency
verfasst von:
Edward O. List, Reetobrata Basu, Silvana Duran-Ortiz, Jackson Krejsa, Elizabeth A. Jensen
Erschienen in:
Reviews in Endocrine and Metabolic Disorders
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Abstract
Nearly one century of research using growth hormone deficient (GHD) mouse lines has contributed greatly toward our knowledge of growth hormone (GH), a pituitary-derived hormone that binds and signals through the GH receptor and affects many metabolic processes throughout life. Although delayed sexual maturation, decreased fertility, reduced muscle mass, increased adiposity, small body size, and glucose intolerance appear to be among the negative characteristics of these GHD mouse lines, these mice still consistently outlive their normal sized littermates. Furthermore, the absence of GH action in these mouse lines leads to enhanced insulin sensitivity (likely due to the lack of GH’s diabetogenic actions), delayed onset for a number of age-associated physiological declines (including cognition, cancer, and neuromusculoskeletal frailty), reduced cellular senescence, and ultimately, extended lifespan. In this review, we provide details about history, availability, growth, physiology, and aging of five commonly used GHD mouse lines.